Price T Rowe Associates Inc Sutro Biopharma, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 26,255 shares of STRO stock, worth $49,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,255
Previous 26,255
-0.0%
Holding current value
$49,359
Previous $77,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding STRO
# of Institutions
137Shares Held
62.4MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$13.5 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$7.89 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$5.64 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$5.32 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $98.1M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...